Net loss of ($2.7 million) during the first quarter of fiscal 2024 compared to net loss of ($2.9 million) during the first quarter of fiscal 2023 Adjusted EBITDA improved to a loss of ($0.7 million) during the first quarter of fiscal 2024 vs. a loss of ($1.3 million) during the first quarter of fiscal 2023 $15.6 million of Booked SaaS ACV as of April 30, 2024 vs. $15.0 million of booked SaaS ACV as of January 31, 2024 Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate e ...

Atlanta, May 29, 2024 (GLOBE NEWSWIRE) -- – Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of RevID, with a 400-bed, Oracle Cerner-EHR based health system with facilities in Southern California. The deal was closed in partnership with Oracle. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill te ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to___________ Commission File Number: 000-28132 STREAMLINE HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Delaware 31-145541 ...

财务数据和关键指标变化 - 2023财年第四季度总收入为5.4百万美元,较2022财年同期的6.7百万美元下降 [20] - 2023财年全年总收入为22.6百万美元,较2022财年的24.9百万美元下降 [20] - 收入下降主要是由于公司的传统维护和支持合同以及专业服务业务收入下降,但SaaS收入有所增长 [20][21] - 2023财年第四季度经营费用为6.5百万美元,较2022财年同期的8.6百万美元下降,主要由于公司整合Avelead和eValuator业务以及专业费用和软件许可费用下降 [22][23] - 2023财年全年经营费用为42百万美元,较2022财年的35.7百万美元增加,主要由于计提了10.8百万美元的商誉减值 [25] - 2023财年第四季度调整后EBITDA为0.4百万美元,较2022财年同期的-0.2百万美元有所改善 [27] - 2023财年全年调整后EBITDA为-1.4百万美元,较2022财年的-3.8百万美元有所改善 [27] 各条业务线数据和关键指标变化 - SaaS收入在2023财年第四季度和全年分别增长0.3百万美元和1.7百万美元 [21] - 公司预计2024财年第一季度SaaS收入将环比下降,全年SaaS收入将低于2023财年 [21] 各个市场数据和关键指标变化 - 无相关内容 公司战略和发展方向及行业竞争 - 公司正在实施更加聚焦的增长策略,包括针对eValuator的替代方案、与Oracle的合作、新的渠道合作伙伴以及现有客户的交叉销售和升级 [16][17] - 公司正在持续投资于技术创新,如RevID的重构、eValuator的AI模型增强、My eValuator的用户体验优化等 [13][14][15] - 公司认为其解决方案能够帮助医疗机构提高收入回收效率,满足行业对新技术投资的需求 [31] 管理层对经营环境和未来前景的评论 - 2023财年是公司业务面临的挑战,但公司的解决方案对客户运营仍有积极影响,公司正努力成为一个更强大、精干和敏捷的组织 [9] - 医疗机构面临着越来越复杂的报销系统和更多的拒付,需要投资新技术来支持收入周期管理 [11][31] - 公司相信其创新和服务模式能够帮助客户实现系统性的改善,从而带来增长 [12] - 公司对未来保持乐观,认为其解决方案的需求仍然存在,并有能力帮助医疗机构应对挑战 [18][31][32] 问答环节重要的提问和回答 问题1 **Matt Hewitt 提问** 询问公司当前的经营环境是否有所改善 [35] **Ben Stilwill 回答** 医疗机构正在重新评估技术优先级,一些机构正在寻求外包解决方案,而另一些机构则希望通过内部改善来解决问题,公司有望从中获益 [36][37][38] 问题2 **Matt Hewitt 提问** 询问公司最近的交叉销售机会的情况 [39] **Ben Stilwill 回答** 公司已经获得两个企业客户的新业务,他们购买了公司的两个旗舰解决方案,这体现了客户对公司服务模式的信任,公司预计未来还有进一步的交叉销售机会 [39][40][41][43] 问题3 **Matt Hewitt 提问** 询问公司AI技术在未来的应用前景 [44] **Ben Stilwill 回答** 公司目前正在eValuator中使用AI技术,未来还可以将其应用于自动化等其他领域,公司正在教育内部专家如何利用这些数字技术,并计划在更多领域部署 [45][46][47]

Exhibit 99.1 Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results ● 14% growth of SaaS revenue in fiscal 2023 compared to fiscal 2022 ● $0.4 million of adjusted EBITDA generated in the fourth quarter of fiscal 2023 compared to ($0.2 million) during the fourth quarter of fiscal 2022; $2.4 million of adjusted EBITDA improvement in fiscal 2023 vs. fiscal 2022 ● ($1.4 million) net loss during the fourth quarter of fiscal 2023, compared to ($2.2 million) during the fourth quarter ...

Following an efficient implementation process, a leading Florida-based healthcare provider is expanding its footprint and utilization of eValuator Atlanta, GA, April 29, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its existing contract with a 1,250 bed, Epic-based academic medical center serving central Florida. The health system recently completed i ...

700-Bed health system adds eValuator™, becomes second healthcare provider leveraging both eValuator and RevID to improve revenue integrity pre-bill Atlanta, GA, April 25, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its partnership with a 5 facility, 700-bed Oracle EHR based health system. The system has been using RevID's automated charge reconciliat ...

公司业绩发布 - Streamline Health Solutions, Inc.将于2024年4月29日发布截至2024年1月31日的三个和十二个月期间的财务业绩[1] - 公司将于2024年4月30日上午9:00举行电话会议，审查业绩并提供公司更新[2] - 电话会议重播将于2024年4月30日下午12:00至2024年5月7日下午12:00提供[3] 公司使命 - Streamline Health Solutions, Inc.致力于帮助医疗机构主动应对收入泄漏并改善财务表现[4]

Streamline expects $4.5 million of additional liquidity will enable achievement of previously announced adjusted EBITDA breakeven of $15.5 million of installed SaaS ARR during the second half of fiscal 2024 Expanded board of directors with appointment of CEO Benjamin Stilwill and Matthew Etheridge Closed private placement of unsecured subordinated notes and warrants and private placement of common stock resulting in aggregate gross proceeds of approximately $4.5 million Modified existing senior loan covenan ...

6 facility New York health system becomes first client leveraging both eValuator and RevID to improve revenue integrity pre-bill Atlanta, GA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded an existing contract with a 6 facility, Oracle Cerner-EHR based health system. The system has been using eValuator for pre-bill code auditing for more than 3 ...